Skip to main content
Clinical Trials/CTRI/2021/11/037734
CTRI/2021/11/037734
Not yet recruiting
未知

Albumin versus crystalloids in fluid resuscitation in severe sepsis and septic shock

VIMSAR0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: A049- Bacterial intestinal infection, unspecifiedHealth Condition 2: O- Medical and SurgicalHealth Condition 3: A419- Sepsis, unspecified organism
Sponsor
VIMSAR
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
VIMSAR

Eligibility Criteria

Inclusion Criteria

  • 1\)AGE\-18\-70 YEARS
  • 2\)AFTER OBTAINING INFORMED CONSENT WE WILL INCLUDE ADULT PATIENTS WITH SEVERE SEPSIS AND SEPTIC SHOCK WITH
  • I)WBC LEVEL \>12000 OR \<4000 MILIMETERCUBE
  • II)HEART RATE \>90/MINUTES
  • III)SYSTOLIC BLOOD PRESSURE \<90MM HG OR MEAN ARTERIAL PRESSURE \<65 MM HG
  • IV)URINE OUTPUT
  • V)LACTATE LEVEL \>2 MILIEQUIVALENTS/L
  • 2\.ASA GRADE I AND II

Exclusion Criteria

  • 1\.PREGNANT WOMEN AND LACTATING MOTHERS
  • 2\.CHILDREN \<14 YEARS
  • 3\.ACUTE BURN PATIENTS
  • 4\.HEART FAILURE

Outcomes

Primary Outcomes

Not specified

Similar Trials